Position in JAZZ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,246,829
+$194,806 QoQ
Shares Held
13,474
-16.5% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#214
of 629 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Atom Investors LP holds $106,011,536 across 52 Biotechnology names. JAZZ ranks #8 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
73,465 | $8,156,818 | |
| 2 | IMNM |
Immunome Inc.
|
297,489 | $6,303,791 | |
| 3 | RARE |
Ultragenyx Pharmaceutical Inc.
|
171,771 | $5,735,433 | |
| 4 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
37,228 | $3,628,985 | |
| 5 | CELC |
Celcuity Inc.
|
34,488 | $3,608,134 | |
| 6 | SNDX |
Syndax Pharmaceuticals Inc
|
162,524 | $3,552,774 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
14,179 | $3,470,593 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
13,474 | $3,246,829 |
All Filings in JAZZ
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,246,829 | 13,474 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,052,023 | 16,144 | Shares | Sole | 2026-05-15 | |
| 2021-06-30 | $2,148,200 | 12,093 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $973,727 | 5,924 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,181,947 | 37,455 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $12,780,341 | 89,630 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $11,391,942 | 103,244 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,427,764 | 34,367 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||